Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin Bremer

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|August 7, 2023
EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cellsVinicio Melo, Levi Collin Nelemans, Martijn Vlaming, et al.
British Journal of Haematology|October 30, 2013
A CD47-blocking TRAIL fusion protein with dual pro-phagocytic and pro-apoptotic anticancer activityValerie R Wiersma, Yuan He, Douwe F Samplonius, et al.
The Journal of Biological Chemistry|January 13, 2005
Simultaneous inhibition of epidermal growth factor receptor (EGFR) signaling and enhanced activation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-mediated apoptosis induction by an scFv:sTRAIL fusion protein with specificity for human EGFREdwin Bremer, Douwe F Samplonius, Linda van Genne, et al.
Scientific Reports|October 16, 2021
CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration propertiesMartijn Vlaming, Vrouyr Bilemjian, Jimena Álvarez Freile, et al.
Immunology Letters|April 26, 2011
Selective elimination of pathogenic synovial fluid T-cells from rheumatoid arthritis and juvenile idiopathic arthritis by targeted activation of Fas-apoptotic signalingEdwin Bremer, Wayel H Abdulahad, Marco de Bruyn, et al.
Arthritis Research & Therapy|December 17, 2011
Frequency of Th17 CD20+ cells in the peripheral blood of rheumatoid arthritis patients is higher compared to healthy subjectsPaul Eggleton, Edwin Bremer, Joanna M Tarr, et al.
Frontiers in Immunology|December 20, 2023
Signal regulatory protein beta 2 is a novel positive regulator of innate anticancer immunityNienke Visser, Levi Collin Nelemans, Yuan He, et al.
Multiple Sclerosis and Related Disorders|August 13, 2015
CD20+inflammatory T-cells are present in blood and brain of multiple sclerosis patients and can be selectively targeted for apoptotic eliminationJanet E Holley, Edwin Bremer, Alexandra C Kendall, et al.
International Journal of Molecular Sciences|August 22, 2019
Galectin-9 Is a Possible Promoter of Immunopathology in Rheumatoid Arthritis by Activation of Peptidyl Arginine Deiminase 4 (PAD-4) in GranulocytesValerie R Wiersma, Alex Clarke, Simon D Pouwels, et al.
Cell Death Discovery|July 5, 2023
Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistanceGhizlane Choukrani, Nienke Visser, Natasha Ustyanovska Avtenyuk, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|August 7, 2023
EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cellsVinicio Melo, Levi Collin Nelemans, Martijn Vlaming, et al.
British Journal of Haematology|October 30, 2013
A CD47-blocking TRAIL fusion protein with dual pro-phagocytic and pro-apoptotic anticancer activityValerie R Wiersma, Yuan He, Douwe F Samplonius, et al.
The Journal of Biological Chemistry|January 13, 2005
Simultaneous inhibition of epidermal growth factor receptor (EGFR) signaling and enhanced activation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-mediated apoptosis induction by an scFv:sTRAIL fusion protein with specificity for human EGFREdwin Bremer, Douwe F Samplonius, Linda van Genne, et al.
Scientific Reports|October 16, 2021
CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration propertiesMartijn Vlaming, Vrouyr Bilemjian, Jimena Álvarez Freile, et al.
Immunology Letters|April 26, 2011
Selective elimination of pathogenic synovial fluid T-cells from rheumatoid arthritis and juvenile idiopathic arthritis by targeted activation of Fas-apoptotic signalingEdwin Bremer, Wayel H Abdulahad, Marco de Bruyn, et al.
Arthritis Research & Therapy|December 17, 2011
Frequency of Th17 CD20+ cells in the peripheral blood of rheumatoid arthritis patients is higher compared to healthy subjectsPaul Eggleton, Edwin Bremer, Joanna M Tarr, et al.
Frontiers in Immunology|December 20, 2023
Signal regulatory protein beta 2 is a novel positive regulator of innate anticancer immunityNienke Visser, Levi Collin Nelemans, Yuan He, et al.
Multiple Sclerosis and Related Disorders|August 13, 2015
CD20+inflammatory T-cells are present in blood and brain of multiple sclerosis patients and can be selectively targeted for apoptotic eliminationJanet E Holley, Edwin Bremer, Alexandra C Kendall, et al.
International Journal of Molecular Sciences|August 22, 2019
Galectin-9 Is a Possible Promoter of Immunopathology in Rheumatoid Arthritis by Activation of Peptidyl Arginine Deiminase 4 (PAD-4) in GranulocytesValerie R Wiersma, Alex Clarke, Simon D Pouwels, et al.
Cell Death Discovery|July 5, 2023
Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistanceGhizlane Choukrani, Nienke Visser, Natasha Ustyanovska Avtenyuk, et al.
Pageof 10